These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 17665320)
1. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 1. Walker K; Kibble A; Shumoogam J IDrugs; 2007 Aug; 10(8):513-6. PubMed ID: 17665320 [No Abstract] [Full Text] [Related]
2. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 2. Walker K IDrugs; 2007 Aug; 10(8):517-9. PubMed ID: 17665321 [No Abstract] [Full Text] [Related]
3. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 4. Walker K; Kibble A; Shumoogam J IDrugs; 2007 Aug; 10(8):523-6. PubMed ID: 17665323 [No Abstract] [Full Text] [Related]
6. American Society of Clinical Oncology-39th Annual Meeting. Taxanes. 31 May-3 June 2003, Chicago, IL, USA. Erlich R; Durrance A IDrugs; 2003 Jul; 6(7):621-2. PubMed ID: 12906002 [No Abstract] [Full Text] [Related]
7. American Association for Cancer Research--96th Annual Meeting. Anticancer agents-part I. Phillips T; Collins T; Davies J IDrugs; 2005 Jun; 8(6):443-5. PubMed ID: 15906182 [No Abstract] [Full Text] [Related]
8. GM1 for taxane-induced neuropathy in breast cancer. Das M Lancet Oncol; 2019 Jul; 20(7):e348. PubMed ID: 31130320 [No Abstract] [Full Text] [Related]
9. American Society of Clinical Oncology--43rd annual meeting. Translating research into practice. Kibble A; Shumoogam J IDrugs; 2007 Aug; 10(8):509-12. PubMed ID: 17665319 [No Abstract] [Full Text] [Related]
10. Improved chemical strategies for the targeted therapy of cancer. Maison W; Frangioni JV Angew Chem Int Ed Engl; 2003 Oct; 42(39):4726-8. PubMed ID: 14562338 [No Abstract] [Full Text] [Related]
15. [Acute typhlitis associated with taxane-based chemotherapy]. Gagliano E; Tonante A; Taranto F; Mamo M; Sturniolo G; Colonese F; Sturniolo G G Chir; 2010; 31(11-12):514-7. PubMed ID: 21232195 [TBL] [Abstract][Full Text] [Related]
16. Emerging nontaxane therapies for metastatic breast cancer. O'Regan R Clin Adv Hematol Oncol; 2012 Mar; 10(3):187-9. PubMed ID: 22402428 [No Abstract] [Full Text] [Related]
17. NCCN: New chemotherapeutic approaches to hormone refractory prostate cancer. Carducci MA; Cancer Control; 2001; 8(6 Suppl 2):62-5. PubMed ID: 11760560 [No Abstract] [Full Text] [Related]
18. American society of clinical oncology - 45th annual meeting. Part 2. Lakeram M; Kibble A IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155 [No Abstract] [Full Text] [Related]
19. American society of clinical oncology - 45th annual meeting. Part 1. Gale S IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154 [No Abstract] [Full Text] [Related]
20. American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA. Erlich R; Durrance A IDrugs; 2003 Jul; 6(7):628-30. PubMed ID: 12906005 [No Abstract] [Full Text] [Related] [Next] [New Search]